Alto Neuroscience, Inc. (NYSE:ANRO - Free Report) - Equities researchers astatine William Blair decreased their FY2028 net estimates for Alto Neuroscience successful a investigation study issued to clients and investors connected Tuesday, October 22nd. William Blair expert M. Minter now forecasts that the…
This communicative appeared connected marketbeat.com, 2024-10-25 13:37:31.